Abstract
Uncontrolled systemic inflammatory immune triggering has hampered the clinical translation of several classes of small-molecule immunomodulators, such as imidazoquinoline TLR7/8 agonists for vaccine design and cancer immunotherapy. By taking advantage of the inherent serum-protein-binding property of lipid motifs and their tendency to accumulate in lymphoid tissue, we designed amphiphilic lipid-polymer conjugates that suppress systemic inflammation but provoke potent lymph-node immune activation. This work provides a rational basis for the design of lipid-polymer amphiphiles for optimized lymphoid targeting.
Keywords:
immunomodulation; innate immunity; lipid amphiphiles; lymph nodes; polymers.
© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Cholesterol / chemistry
-
Imidazoles / chemistry
-
Immunity, Innate* / drug effects
-
Immunologic Factors / chemistry
-
Immunologic Factors / metabolism
-
Immunologic Factors / pharmacology
-
Lipids / chemistry
-
Lymph Nodes / drug effects
-
Lymph Nodes / immunology
-
Macrophages / cytology
-
Macrophages / drug effects
-
Macrophages / metabolism
-
Mice
-
NF-kappa B / metabolism
-
Polymers / chemistry
-
Quinolines / chemistry
-
Quinolines / pharmacology
-
RAW 264.7 Cells
-
Small Molecule Libraries / chemistry
-
Small Molecule Libraries / pharmacology
-
Toll-Like Receptor 7 / agonists*
-
Toll-Like Receptor 7 / metabolism
-
Toll-Like Receptor 8 / agonists*
-
Toll-Like Receptor 8 / metabolism
Substances
-
Imidazoles
-
Immunologic Factors
-
Lipids
-
NF-kappa B
-
Polymers
-
Quinolines
-
Small Molecule Libraries
-
Toll-Like Receptor 7
-
Toll-Like Receptor 8
-
Cholesterol